Attovia Therapeutics
Founded 2023 · 54 employees on LinkedIn · 7 known investors
Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options. Its team includes a leadership team, board of directors, and scientific advisors experienced in drug development and company building.
Founders & leadership
Attovia Therapeutics was founded in 2023 by Zaneta Odrowaz.
ZO
Zaneta OdrowazinFounder · Chief Business Officer
Investors · 7
Founder mafia
2 people who came through Attovia Therapeutics went on to found or lead other companies.
Competitors · 2
by search overlap
IQVIA59 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Mission BioCapital Platinum Program Holdings LLC29 shared keywordsMission BioCapital is an early-stage venture capital firm that provides capital and shared lab space to life science startups, supporting founders from initial experiments through to the clinic. Founded in 2009, it invests in early-stage life science companies and is currently deploying its fifth fund.
Companies competing with Attovia Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Goldman Sachs-backed biopharma company Attovia Therapeutics files for US IPOpharma.economictimes.indiatimes.com · Jul 2026
Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immuno - BioSpacebiospace.com · Jul 2026
Braveheart, Attovia join next wave of biotech IPOs | BioPharma Divebiopharmadive.com · Jul 2026
Attovia files for IPO to take on Sanofi and Regeneron’s Dupixentfiercebiotech.com · Jul 2026Frequently asked questions
- What does Attovia Therapeutics do?
- Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options. Its team includes a leadership team, board of directors, and scientific advisors experienced in drug development and company building.
- Who founded Attovia Therapeutics?
- Attovia Therapeutics was founded by Zaneta Odrowaz in 2023.
- Who are Attovia Therapeutics's investors?
- Attovia Therapeutics's investors include EcoR1 Capital, Frazier Life Sciences, Illumina Ventures, Nextech Invest, Sanofi Ventures, Vida Ventures, Goldman Sachs.